Examkin

Question

Difficulty: HardGynecologic Oncology

Following a routine well-woman examination, a 52-year-old nulligravid patient is asked to return to the clinic to discuss her cervical cytology results. She transitioned through menopause at age 50 and denies any postmenopausal bleeding, pelvic pressure, or abnormal vaginal discharge. Her current health is excellent with no chronic medical conditions, and she takes no medications. Pelvic examination demonstrates normal external genitalia, a parous-appearing cervix without gross lesions, and a small, mobile uterus without adnexal masses. The cytology report notes the presence of atypical glandular cells (AGC). A concurrent high-risk human papillomavirus (HPV) test is negative. Which of the following is the most appropriate next step in the diagnostic evaluation?

  1. Colposcopy, endocervical sampling, and endometrial biopsyAnswer
  2. B
    Colposcopy and endocervical sampling only
  3. C
    Transvaginal ultrasound
  4. D
    Loop electrosurgical excision procedure
  5. E
    Repeat human papillomavirus testing and Papanicolaou test in 12 months

Answer

The most appropriate next step is to perform colposcopy, endocervical sampling, and endometrial biopsy concurrently.
The finding of atypical glandular cells (AGC) on cervical cytology is concerning because it is associated with a high risk of significant pathology, including cervical adenocarcinoma in situ, invasive cervical adenocarcinoma, and endometrial adenocarcinoma. Because the glandular cells could originate from either the cervix or the uterus, standard guidelines require comprehensive evaluation. For all women aged 35 years and older with AGC (as well as younger women with risk factors for endometrial cancer, such as obesity or chronic anovulation), the required next step is a combination of colposcopy, endocervical sampling, and endometrial biopsy. This triad ensures that all potential anatomic sources of the abnormal cells are histologically evaluated.

Step-by-Step Solution

1
Analyze the cervical cytology result.
The Pap test shows Atypical Glandular Cells (AGC), which is a high-risk finding.
Unlike squamous cell abnormalities, AGC has a higher positive predictive value for underlying premalignancy or malignancy (such as cervical adenocarcinoma in situ, invasive cervical adenocarcinoma, or endometrial adenocarcinoma).
2
Determine the required diagnostic procedures based on the patient's age and risk factors.
The patient is 52 years old. Guidelines mandate that all women ≥\geq 35 years of age with AGC undergo evaluation of the endometrium in addition to the cervix and endocervix.
The source of the atypical glandular cells can be the endocervical canal or the endometrial cavity. Age ≥\geq 35 is a primary risk factor for endometrial cancer.
3
Synthesize the management plan.
The patient must undergo colposcopy (to evaluate the ectocervix), endocervical sampling (to evaluate the endocervical canal), and an endometrial biopsy (to evaluate the endometrium).
This triad of tests ensures comprehensive sampling of all potential anatomic sources for the atypical glandular cells, preventing a missed diagnosis of occult adenocarcinoma.

Key Concept

Management of Atypical Glandular Cells (AGC) on cervical cytology
Estimated Time:1m 15s
Rate this question

Topics

Gynecologic Oncology

More questions from this topic